SlideShare a Scribd company logo
Metabolic effects of
pancreatic hormones
By Yerukneh Solomon
7/18/2017 1
Outlines
 Introduction
 Pancreatic hormones synthesis and
secretion
 Pancreatic hormones effects on
metabolism
 Summary
7/18/2017 2
Introduction
Pancreas
 Pancreas contains exocrine & endocrine cells
 Roughly 99% of the cells of the pancreas are
arranged in clusters called acini.
The acini produce digestive enzymes, which flow into
the GIT.
 Endocrine cells are called Islets of Langerhans,
1-2% of pancreatic tissue.
7/18/2017 3
7/18/2017 4
Introduc…
 There are 4-types of
endocrine cells
1. α-cells: secret
glucagon (25%)
2. β-Cells: secret
insulin (65%)
3. δ-Cells: secret
somatostatin (8%)
4. F-Cells: secret
pancreatic
polypeptides (2%)
7/18/2017 5
Insulin Chemistry and Synthesis
Insulin is a small protein;
human insulin has a molecular weight of 5808. It is
composed of two amino acid chains connected to each
other by disulfide linkages
Beta cells - beginning with translation of the insulin
RNA by ribosomes attached to the ER to form an insulin
preprohormone (11500) - cleaved in the ER to form a
proinsulin (9000) - further cleaved in the Golgi
apparatus to form insulin - secretory granules
unbound form; it has a plasma half-life that averages
only about 6 minutes - degraded by the enzyme
insulinase mainly in the liver, to a lesser extent in the7/18/2017 6
7/18/2017 7
7/18/2017 8
7/18/2017 9
7/18/2017 10
Cellular effect of insulin
7/18/2017 11
Carbohydrate Metabolism
• Immediately after a high-carbohydrate meal, rapid
secretion of insulin occur
• The normal resting muscle membrane is only
slightly permeable to glucose, except when the
muscle
• fiber is stimulated by insulin
• Moderate or heavy exercise
• Few hours after a meal because of insulin –
Glucose stored as muscle GLYCOGEN – used
during anaerobic exercise
7/18/2017 12
7/18/2017 13
Carbohydrate Metabolism
• Glucose absorbed after a meal to be stored
almost immediately in the liver in the form of
glycogen
 Insulin promotes storage by:
 Increasing the activity of the
Glucokinase,
 inactivating liver phosphorylase
 Increasing the activities of glycogen
synthase
7/18/2017 14
7/18/2017 15
Carbohydrate Metabolism
Glucose Is Released from the Liver Between Meals
1. The decreasing blood glucose causes the
pancreas to decrease its insulin secretion.
2. Stopping further synthesis of glycogen in the
liver and preventing further uptake of glucose by
the liver from the blood.
3. The lack of insulin along with increase of
glucagon, activates the enzyme phosphorylase,
4. The enzyme glucose phosphatase, becomes
activated 7/18/2017 16
Carbohydrate Metabolism
• When the quantity of glucose entering the liver
cells is more than can be stored as glycogen,
Conversion of excess glucose into fatty acids
• Insulin also inhibits gluconeogenesis by:
 Decreasing the quantities and activities of the
liver enzymes required for gluconeogenesis
 Decreases the release of amino acids from
muscle and other extrahepatic tissues
• Brain cells use only glucose for energy
7/18/2017 17
Fat Metabolism
Insulin acts as fat sparer.
Promotes fatty acid synthesis in liver from excess
glucose
1. Insulin increases the transport of glucose into the
liver cells
2. Energy from glucose via citric acid cycle - excess
of citrate and isocitrate ions - activates acetyl CoA
carboxylase – acetyl CoA to form malonyl CoA
Fat storage in adipose tissue
 Fatty acids (triglycerides) are then transported from
the liver by way of the blood lipoproteins to the
adipose cells.
7/18/2017 18
Fat Metabolism
 Insulin promotes glucose transport into the fat
cells
 Insulin inhibits the action of hormone-sensitive
lipase
 insulin deficiency - free fatty acid
 FFA become main energy substrate
The excess of fatty acids in the plasma
promotes liver conversion of some of the fatty
acids into phospholipids and cholesterol
7/18/2017 19
7/18/2017 20
Protein Metabolism and Growth
1. Insulin stimulates transport of many of the amino
acids into the cells
2. Insulin increases the rate of transcription of
selected DNA genetic sequences
3. Insulin increases the translation of mRNA
4. Insulin inhibits the catabolism of proteins
5. In the liver, insulin depresses the rate of
gluconeogenesis - conserves the amino acids in
the protein stores of the body
7/18/2017 21
7/18/2017 22
fasting level of blood glucose of 80 to 90 mg/100 ml,
the rate of insulin secretion is minimal — 25 ng/min/kg
of body weight
7/18/2017 23
7/18/2017 24
Glucagon and Its Functions
Glucagon, a hormone secreted by the alpha cells
of the islets of Langerhans when the blood
glucose concentration falls
Glucagon - large polypeptide - molecular weight
of 3485 – chain of 29 amino acids
1 µg/kg of glucagon can elevate the blood glucose
concentration about 20 mg/100 ml of blood (25 per
cent increase) in about 20 minutes
(1) breakdown of liver glycogen (glycogenolysis)
(2) increased gluconeogenesis in the liver
7/18/2017 25
Glucagon
 Synthesis, Secretion and metabolism
◦ Synthesized from the preprohormone
precursor called preproglucagon in the α-
cells of islets.
◦ Preproglucagon is converted into
proglucagon, which gives rise to
glucagon.
◦ Secreted from α-cells in the islets of
Langerhans of pancreas.
◦ It is also secreted from A cells of stomach
and L cells of intestine.
7/18/2017 26
 Chemistry And Half-life
◦ Polypeptide with a molecular weight of
3,485.
◦ It contains 29 amino acids.
◦ Half-life of glucagon is 3 to 6 minutes.
7/18/2017 27
 Metabolism
◦ About 30% of glucagon is degraded in liver
and 20% in kidney.
◦ The cleaved glucagon fragments are
excreted through urine.
◦ 50% of the circulating glucagon is
degraded in blood itself by enzymes such
as serine and cysteine proteases
7/18/2017 28
 Actions Of Glucagon
◦ Actions of glucagon are antagonistic
to those of insulin
◦ It increases:
 Blood glucose level,
 Peripheral utilization of lipids
 Conversion of proteins into glucose
7/18/2017 29
On Carbohydrate Metabolism
Glucagon increases the blood glucose level
by:
 Increasing glycogenolysis in liver.
 Increasing gluconeogenesis in liver
 Decreasing glycolysis
 Decreasing glycogenolysis
7/18/2017 30
Cellular effect of glucagon
 Glucagon causes glycogenolysis in
the liver, which in turn increases the
blood glucose concentration within
minutes.
7/18/2017 31
7/18/2017 32
glycogenolysis
1. Glucagon activates adenylyl cyclase in the hepatic
cell membrane - cAMP - protein kinase,
2. Which activates phosphorylase b kinase,
3. Which converts phosphorylase b into phosphorylase
a,
4. Which promotes the degradation of glycogen into
glucose-1-phosphate,
5. Which then is dephosphorylated; and the glucose is
released from the liver cells.7/18/2017 33
7/18/2017 34
7/18/2017 35
Gluconeogenesis
◦ by:
 Activating the enzymes, which convert
pyruvate into phosphoenol pyruvate
 Increasing the transport of amino acids into
the liver cells.
 The amino acids are utilized for glucose
formation
7/18/2017 36
7/18/2017 37
Gluconeogenesis
increase the rate of amino acid uptake by the liver cells
and then the conversion of many of the amino acids to
glucose
activation of the enzyme system for converting pyruvate
to phosphoenolpyruvate, a rate-limiting step in
gluconeogenesis
glucagon activates adipose cell lipase, making
increased quantities of fatty acids available to the energy
systems of the body
Glucagon also inhibits the storage of triglycerides in
the liver, which prevents the liver from removing fatty
acids from the blood 7/18/2017 38
On Fat Metabolism
◦ Glucagon shows lipolytic and ketogenic actions.
◦ It increases lipolysis by increasing the release of
free fatty acids from adipose tissue and making
them available for peripheral utilization.
◦ The lipolytic activity of glucagon, in turn
promotes ketogenesis (formation of ketone
bodies) in liver
7/18/2017 39
◦ In the adipocyte, glucagon activates
hormone- sensitive lipase,
 the enzyme that breaks down triglycerides
(stored fat) into diacylglycerol and free fatty
acids, releasing them into the circulation.
◦ Glycerol released into the circulation can
be utilized in the liver for gluconeogenesis
◦ Free fatty acids are used as fuel by most
tissues,
7/18/2017 40
7/18/2017 41
7/18/2017 42
Somatostatin
 Somatostatin is secreted from:
Hypothalamus
D cells (δ-cells) in islets of Langerhans of
pancreas
D cells in stomach and upper part of small
intestine.
 Somatostatin brings out its actions through cAMP
7/18/2017 43
Chemistry ,Half-life & metabolism
 Somatostatin is a polypeptide.
 It is synthesized in two forms, namely
somatostatin-14 and somatostatin-28
 Both the forms have similar actions.
 Half-life of somatostatin is 2 to 4 minutes.
 Somatostatin is degraded in liver and
kidney.
7/18/2017 44
 Actions Of Somatostatin
1. Somatostatin acts within pancreas,
inhibits β and α cells,
2. It decreases the motility of stomach,
duodenum and gallbladder
3. It reduces the secretion of gastrin, CCK,
GIP and VIP
4. Hypothalamic somatostatin inhibits the
secretion of GH and TSH
7/18/2017 45
Regulation Of Secretion Of Somatostatin
 Pancreatic Somatostatin
 Secretion of pancreatic somatostatin is
stimulated by glucose, amino acids and CCK.
 The tumor of D cells of islets of Langerhans
causes hypersecretion of somatostatin.
 It leads to hyperglycemia and other symptoms
of diabetes mellitus.
7/18/2017 46
Pancreatic Polypeptide
 Source Of Secretion
◦ Pancreatic polypeptide is secreted by F
cells or PP cells in the islets of
Langerhans of pancreas.
 Chemistry And Half-life
◦ Pancreatic polypeptide is a polypeptide
with 36 amino acids.
◦ Its half-life is 5 minutes.
7/18/2017 47
Synthesis and metabolism
 Pancreatic polypeptide is synthesized
from preprohormone precursor called
prepropancreatic polypeptide in the PP
cells of islets
 Pancreatic polypeptide is degraded and
removed from circulation mainly in
kidney.
7/18/2017 48
Actions Of Pancreatic
Polypeptide
◦ Exact physiological action of
pancreatic polypeptide is not known.
◦ It is believed to increase the secretion
of glucagon from α-cells in islets of
Langerhans.
 Pancreatic polypeptide brings out its
actions through cAMP.
7/18/2017 49
 Regulation Of Secretion
◦ Secretion of pancreatic polypeptide is
stimulated by the presence of chyme
containing more proteins in the small
intestine.
7/18/2017 50
Clinical correlations
7/18/2017 51
Hypoglycemia
 Hypoglycemia is common in insulin-treated
diabetic patients and also occurs occasionally in
patients treated with the oral hypoglycemic
sulfonylurea agents.
 Hypoglycemia may range from very mild lowering
of glycemia (60-70 mg/dl) with minimal or no
symptoms, to severe hypoglycemia with very low
levels of glucose (<40 mg/dl) and neurologic
impairment.
7/18/2017 52
7/18/2017 53
Clinical correlation
7/18/2017 54
References
 Guyton & Hall:2011, Textbook of Medical
Physiology, 12th ed. Insulin, glucagon and DM
chapter XIV,
 Williams textbook of endocrinology, 13th
edition.
 Berney, and Levy, physiology, 6th edition.
 L. Sherwood, human physiology, 7th edition.
 Vander's, human physiology,11th edition.
7/18/2017 55
Thank You…
7/18/2017 56

More Related Content

What's hot

Glycogen metabolism ppt
Glycogen metabolism pptGlycogen metabolism ppt
Glycogen metabolism ppt
Phari Dajangju
 
Digestion of lipids
Digestion of lipidsDigestion of lipids
Digestion of lipids
reachminu
 
Presentation glucose transporters
Presentation glucose transportersPresentation glucose transporters
Presentation glucose transporters
kiro94
 
white blood cell
white blood cellwhite blood cell
white blood cell
Tagore medical College
 
Disorders of Lipoprotein Metabolism
Disorders of Lipoprotein MetabolismDisorders of Lipoprotein Metabolism
Disorders of Lipoprotein Metabolism
ASHIKH SEETHY
 
GSD, glycogen storage disease
GSD, glycogen storage disease GSD, glycogen storage disease
GSD, glycogen storage disease
sruthi ramamurthy
 
Steroid Hormones
Steroid HormonesSteroid Hormones
Steroid Hormones
Mr.S.SEETARAM SWAMY
 
Proteoglycan
ProteoglycanProteoglycan
Proteoglycan
Ali Raza Ph.D
 
Disorders of lipid metabolism case studies-1
Disorders of lipid metabolism  case studies-1Disorders of lipid metabolism  case studies-1
Disorders of lipid metabolism case studies-1
Namrata Chhabra
 
Non protein nitrogen
Non protein nitrogenNon protein nitrogen
Non protein nitrogen
Shahid Nawaz
 
Glucose Transporters.pptx
Glucose Transporters.pptxGlucose Transporters.pptx
Glucose Transporters.pptx
Bangaluru
 
Glucagon
GlucagonGlucagon
Glycogen metabolism and it’s regulation
Glycogen metabolism and it’s regulationGlycogen metabolism and it’s regulation
Glycogen metabolism and it’s regulation
BiochemistrySGRDIMSAR
 
Metabolic effect of insulin and glucagon
Metabolic effect of insulin and glucagonMetabolic effect of insulin and glucagon
Metabolic effect of insulin and glucagon
Hari Sharan Makaju
 
Regulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesisRegulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesis
SKYFALL
 
Plasma proteins
Plasma proteinsPlasma proteins
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
Ramesh Gupta
 
Uronic acid pathway
Uronic acid pathwayUronic acid pathway
Uronic acid pathway
Ashok Katta
 
Urea and Uric acid
Urea and Uric acid Urea and Uric acid
Urea and Uric acid
Abdi Qani Yuusuf
 
Dr ravi lipid profile
Dr ravi lipid profileDr ravi lipid profile
Dr ravi lipid profile
Ravi Jain
 

What's hot (20)

Glycogen metabolism ppt
Glycogen metabolism pptGlycogen metabolism ppt
Glycogen metabolism ppt
 
Digestion of lipids
Digestion of lipidsDigestion of lipids
Digestion of lipids
 
Presentation glucose transporters
Presentation glucose transportersPresentation glucose transporters
Presentation glucose transporters
 
white blood cell
white blood cellwhite blood cell
white blood cell
 
Disorders of Lipoprotein Metabolism
Disorders of Lipoprotein MetabolismDisorders of Lipoprotein Metabolism
Disorders of Lipoprotein Metabolism
 
GSD, glycogen storage disease
GSD, glycogen storage disease GSD, glycogen storage disease
GSD, glycogen storage disease
 
Steroid Hormones
Steroid HormonesSteroid Hormones
Steroid Hormones
 
Proteoglycan
ProteoglycanProteoglycan
Proteoglycan
 
Disorders of lipid metabolism case studies-1
Disorders of lipid metabolism  case studies-1Disorders of lipid metabolism  case studies-1
Disorders of lipid metabolism case studies-1
 
Non protein nitrogen
Non protein nitrogenNon protein nitrogen
Non protein nitrogen
 
Glucose Transporters.pptx
Glucose Transporters.pptxGlucose Transporters.pptx
Glucose Transporters.pptx
 
Glucagon
GlucagonGlucagon
Glucagon
 
Glycogen metabolism and it’s regulation
Glycogen metabolism and it’s regulationGlycogen metabolism and it’s regulation
Glycogen metabolism and it’s regulation
 
Metabolic effect of insulin and glucagon
Metabolic effect of insulin and glucagonMetabolic effect of insulin and glucagon
Metabolic effect of insulin and glucagon
 
Regulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesisRegulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesis
 
Plasma proteins
Plasma proteinsPlasma proteins
Plasma proteins
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Uronic acid pathway
Uronic acid pathwayUronic acid pathway
Uronic acid pathway
 
Urea and Uric acid
Urea and Uric acid Urea and Uric acid
Urea and Uric acid
 
Dr ravi lipid profile
Dr ravi lipid profileDr ravi lipid profile
Dr ravi lipid profile
 

Similar to Metabolic effect of pancreatic hormones,insulin glucagon and PPP(PANCREATIC POLY PEPTIDE)

diabetes mellitus  / dental implant courses by Indian dental academy 
diabetes mellitus   / dental implant courses by Indian dental academy diabetes mellitus   / dental implant courses by Indian dental academy 
diabetes mellitus  / dental implant courses by Indian dental academy 
Indian dental academy
 
Pancreas
PancreasPancreas
Pancreas
PoojaVishnoi7
 
Pancreas
PancreasPancreas
DIABETES MELLITUS - BIOCHEMISTRY
DIABETES MELLITUS - BIOCHEMISTRYDIABETES MELLITUS - BIOCHEMISTRY
DIABETES MELLITUS - BIOCHEMISTRY
YESANNA
 
Glycogen & gluconeogenesis 2020
Glycogen & gluconeogenesis 2020Glycogen & gluconeogenesis 2020
Glycogen & gluconeogenesis 2020
Ayman Hany
 
9 blood glucose
9 blood glucose9 blood glucose
9 blood glucosedream10f
 
Insulin, glucagon, and diabetes mellitus
Insulin, glucagon, and diabetes mellitusInsulin, glucagon, and diabetes mellitus
Insulin, glucagon, and diabetes mellitus
bigboss716
 
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasisHormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
Hamid Ur-Rahman
 
Glucagon-9.pptx- Physiology, functions, regulation
Glucagon-9.pptx- Physiology, functions, regulationGlucagon-9.pptx- Physiology, functions, regulation
Glucagon-9.pptx- Physiology, functions, regulation
Sai Sailesh Kumar Goothy
 
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptxUnit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
ChevallaMaheshwari
 
Unit-2_first_year_bkg_final[1].pptx
Unit-2_first_year_bkg_final[1].pptxUnit-2_first_year_bkg_final[1].pptx
Unit-2_first_year_bkg_final[1].pptx
ChevallaMaheshwari
 
Glyceroneogenesis
GlyceroneogenesisGlyceroneogenesis
Glyceroneogenesis
Sreya Radhakrishnan
 
18. endocrine pancreas
18. endocrine pancreas18. endocrine pancreas
18. endocrine pancreasNasir Koko
 
Pancreas.ppt
Pancreas.pptPancreas.ppt
Pancreas.ppt
Medical Knowledge
 
3-The Endocrine Pancreas.ppt
3-The Endocrine Pancreas.ppt3-The Endocrine Pancreas.ppt
3-The Endocrine Pancreas.ppt
SudhaKavitha1
 
9. integration of metabolism
9. integration of metabolism9. integration of metabolism
9. integration of metabolism
Ministry of Education, Ethiopia
 
Pancreas
PancreasPancreas
Pancreas
ANU KUNNATH
 

Similar to Metabolic effect of pancreatic hormones,insulin glucagon and PPP(PANCREATIC POLY PEPTIDE) (20)

diabetes mellitus  / dental implant courses by Indian dental academy 
diabetes mellitus   / dental implant courses by Indian dental academy diabetes mellitus   / dental implant courses by Indian dental academy 
diabetes mellitus  / dental implant courses by Indian dental academy 
 
Blood glucose Regulation Dr veerendra
Blood glucose Regulation Dr veerendraBlood glucose Regulation Dr veerendra
Blood glucose Regulation Dr veerendra
 
Pancreas
PancreasPancreas
Pancreas
 
Pancreas
PancreasPancreas
Pancreas
 
Pancreas
PancreasPancreas
Pancreas
 
DIABETES MELLITUS - BIOCHEMISTRY
DIABETES MELLITUS - BIOCHEMISTRYDIABETES MELLITUS - BIOCHEMISTRY
DIABETES MELLITUS - BIOCHEMISTRY
 
Glycogen & gluconeogenesis 2020
Glycogen & gluconeogenesis 2020Glycogen & gluconeogenesis 2020
Glycogen & gluconeogenesis 2020
 
9 blood glucose
9 blood glucose9 blood glucose
9 blood glucose
 
Insulin, glucagon, and diabetes mellitus
Insulin, glucagon, and diabetes mellitusInsulin, glucagon, and diabetes mellitus
Insulin, glucagon, and diabetes mellitus
 
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasisHormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
Hormonal Regulation: glycolysis/glucogenesis-Glucose homeostasis
 
Insulin, glucagon & dm
Insulin, glucagon & dmInsulin, glucagon & dm
Insulin, glucagon & dm
 
Glucagon-9.pptx- Physiology, functions, regulation
Glucagon-9.pptx- Physiology, functions, regulationGlucagon-9.pptx- Physiology, functions, regulation
Glucagon-9.pptx- Physiology, functions, regulation
 
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptxUnit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
Unit-2_first_year_bkg_final[1] carbohydrate metabolism.pptx
 
Unit-2_first_year_bkg_final[1].pptx
Unit-2_first_year_bkg_final[1].pptxUnit-2_first_year_bkg_final[1].pptx
Unit-2_first_year_bkg_final[1].pptx
 
Glyceroneogenesis
GlyceroneogenesisGlyceroneogenesis
Glyceroneogenesis
 
18. endocrine pancreas
18. endocrine pancreas18. endocrine pancreas
18. endocrine pancreas
 
Pancreas.ppt
Pancreas.pptPancreas.ppt
Pancreas.ppt
 
3-The Endocrine Pancreas.ppt
3-The Endocrine Pancreas.ppt3-The Endocrine Pancreas.ppt
3-The Endocrine Pancreas.ppt
 
9. integration of metabolism
9. integration of metabolism9. integration of metabolism
9. integration of metabolism
 
Pancreas
PancreasPancreas
Pancreas
 

Recently uploaded

planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 

Metabolic effect of pancreatic hormones,insulin glucagon and PPP(PANCREATIC POLY PEPTIDE)

  • 1. Metabolic effects of pancreatic hormones By Yerukneh Solomon 7/18/2017 1
  • 2. Outlines  Introduction  Pancreatic hormones synthesis and secretion  Pancreatic hormones effects on metabolism  Summary 7/18/2017 2
  • 3. Introduction Pancreas  Pancreas contains exocrine & endocrine cells  Roughly 99% of the cells of the pancreas are arranged in clusters called acini. The acini produce digestive enzymes, which flow into the GIT.  Endocrine cells are called Islets of Langerhans, 1-2% of pancreatic tissue. 7/18/2017 3
  • 5. Introduc…  There are 4-types of endocrine cells 1. α-cells: secret glucagon (25%) 2. β-Cells: secret insulin (65%) 3. δ-Cells: secret somatostatin (8%) 4. F-Cells: secret pancreatic polypeptides (2%) 7/18/2017 5
  • 6. Insulin Chemistry and Synthesis Insulin is a small protein; human insulin has a molecular weight of 5808. It is composed of two amino acid chains connected to each other by disulfide linkages Beta cells - beginning with translation of the insulin RNA by ribosomes attached to the ER to form an insulin preprohormone (11500) - cleaved in the ER to form a proinsulin (9000) - further cleaved in the Golgi apparatus to form insulin - secretory granules unbound form; it has a plasma half-life that averages only about 6 minutes - degraded by the enzyme insulinase mainly in the liver, to a lesser extent in the7/18/2017 6
  • 11. Cellular effect of insulin 7/18/2017 11
  • 12. Carbohydrate Metabolism • Immediately after a high-carbohydrate meal, rapid secretion of insulin occur • The normal resting muscle membrane is only slightly permeable to glucose, except when the muscle • fiber is stimulated by insulin • Moderate or heavy exercise • Few hours after a meal because of insulin – Glucose stored as muscle GLYCOGEN – used during anaerobic exercise 7/18/2017 12
  • 14. Carbohydrate Metabolism • Glucose absorbed after a meal to be stored almost immediately in the liver in the form of glycogen  Insulin promotes storage by:  Increasing the activity of the Glucokinase,  inactivating liver phosphorylase  Increasing the activities of glycogen synthase 7/18/2017 14
  • 16. Carbohydrate Metabolism Glucose Is Released from the Liver Between Meals 1. The decreasing blood glucose causes the pancreas to decrease its insulin secretion. 2. Stopping further synthesis of glycogen in the liver and preventing further uptake of glucose by the liver from the blood. 3. The lack of insulin along with increase of glucagon, activates the enzyme phosphorylase, 4. The enzyme glucose phosphatase, becomes activated 7/18/2017 16
  • 17. Carbohydrate Metabolism • When the quantity of glucose entering the liver cells is more than can be stored as glycogen, Conversion of excess glucose into fatty acids • Insulin also inhibits gluconeogenesis by:  Decreasing the quantities and activities of the liver enzymes required for gluconeogenesis  Decreases the release of amino acids from muscle and other extrahepatic tissues • Brain cells use only glucose for energy 7/18/2017 17
  • 18. Fat Metabolism Insulin acts as fat sparer. Promotes fatty acid synthesis in liver from excess glucose 1. Insulin increases the transport of glucose into the liver cells 2. Energy from glucose via citric acid cycle - excess of citrate and isocitrate ions - activates acetyl CoA carboxylase – acetyl CoA to form malonyl CoA Fat storage in adipose tissue  Fatty acids (triglycerides) are then transported from the liver by way of the blood lipoproteins to the adipose cells. 7/18/2017 18
  • 19. Fat Metabolism  Insulin promotes glucose transport into the fat cells  Insulin inhibits the action of hormone-sensitive lipase  insulin deficiency - free fatty acid  FFA become main energy substrate The excess of fatty acids in the plasma promotes liver conversion of some of the fatty acids into phospholipids and cholesterol 7/18/2017 19
  • 21. Protein Metabolism and Growth 1. Insulin stimulates transport of many of the amino acids into the cells 2. Insulin increases the rate of transcription of selected DNA genetic sequences 3. Insulin increases the translation of mRNA 4. Insulin inhibits the catabolism of proteins 5. In the liver, insulin depresses the rate of gluconeogenesis - conserves the amino acids in the protein stores of the body 7/18/2017 21
  • 23. fasting level of blood glucose of 80 to 90 mg/100 ml, the rate of insulin secretion is minimal — 25 ng/min/kg of body weight 7/18/2017 23
  • 25. Glucagon and Its Functions Glucagon, a hormone secreted by the alpha cells of the islets of Langerhans when the blood glucose concentration falls Glucagon - large polypeptide - molecular weight of 3485 – chain of 29 amino acids 1 µg/kg of glucagon can elevate the blood glucose concentration about 20 mg/100 ml of blood (25 per cent increase) in about 20 minutes (1) breakdown of liver glycogen (glycogenolysis) (2) increased gluconeogenesis in the liver 7/18/2017 25
  • 26. Glucagon  Synthesis, Secretion and metabolism ◦ Synthesized from the preprohormone precursor called preproglucagon in the α- cells of islets. ◦ Preproglucagon is converted into proglucagon, which gives rise to glucagon. ◦ Secreted from α-cells in the islets of Langerhans of pancreas. ◦ It is also secreted from A cells of stomach and L cells of intestine. 7/18/2017 26
  • 27.  Chemistry And Half-life ◦ Polypeptide with a molecular weight of 3,485. ◦ It contains 29 amino acids. ◦ Half-life of glucagon is 3 to 6 minutes. 7/18/2017 27
  • 28.  Metabolism ◦ About 30% of glucagon is degraded in liver and 20% in kidney. ◦ The cleaved glucagon fragments are excreted through urine. ◦ 50% of the circulating glucagon is degraded in blood itself by enzymes such as serine and cysteine proteases 7/18/2017 28
  • 29.  Actions Of Glucagon ◦ Actions of glucagon are antagonistic to those of insulin ◦ It increases:  Blood glucose level,  Peripheral utilization of lipids  Conversion of proteins into glucose 7/18/2017 29
  • 30. On Carbohydrate Metabolism Glucagon increases the blood glucose level by:  Increasing glycogenolysis in liver.  Increasing gluconeogenesis in liver  Decreasing glycolysis  Decreasing glycogenolysis 7/18/2017 30
  • 31. Cellular effect of glucagon  Glucagon causes glycogenolysis in the liver, which in turn increases the blood glucose concentration within minutes. 7/18/2017 31
  • 33. glycogenolysis 1. Glucagon activates adenylyl cyclase in the hepatic cell membrane - cAMP - protein kinase, 2. Which activates phosphorylase b kinase, 3. Which converts phosphorylase b into phosphorylase a, 4. Which promotes the degradation of glycogen into glucose-1-phosphate, 5. Which then is dephosphorylated; and the glucose is released from the liver cells.7/18/2017 33
  • 36. Gluconeogenesis ◦ by:  Activating the enzymes, which convert pyruvate into phosphoenol pyruvate  Increasing the transport of amino acids into the liver cells.  The amino acids are utilized for glucose formation 7/18/2017 36
  • 38. Gluconeogenesis increase the rate of amino acid uptake by the liver cells and then the conversion of many of the amino acids to glucose activation of the enzyme system for converting pyruvate to phosphoenolpyruvate, a rate-limiting step in gluconeogenesis glucagon activates adipose cell lipase, making increased quantities of fatty acids available to the energy systems of the body Glucagon also inhibits the storage of triglycerides in the liver, which prevents the liver from removing fatty acids from the blood 7/18/2017 38
  • 39. On Fat Metabolism ◦ Glucagon shows lipolytic and ketogenic actions. ◦ It increases lipolysis by increasing the release of free fatty acids from adipose tissue and making them available for peripheral utilization. ◦ The lipolytic activity of glucagon, in turn promotes ketogenesis (formation of ketone bodies) in liver 7/18/2017 39
  • 40. ◦ In the adipocyte, glucagon activates hormone- sensitive lipase,  the enzyme that breaks down triglycerides (stored fat) into diacylglycerol and free fatty acids, releasing them into the circulation. ◦ Glycerol released into the circulation can be utilized in the liver for gluconeogenesis ◦ Free fatty acids are used as fuel by most tissues, 7/18/2017 40
  • 43. Somatostatin  Somatostatin is secreted from: Hypothalamus D cells (δ-cells) in islets of Langerhans of pancreas D cells in stomach and upper part of small intestine.  Somatostatin brings out its actions through cAMP 7/18/2017 43
  • 44. Chemistry ,Half-life & metabolism  Somatostatin is a polypeptide.  It is synthesized in two forms, namely somatostatin-14 and somatostatin-28  Both the forms have similar actions.  Half-life of somatostatin is 2 to 4 minutes.  Somatostatin is degraded in liver and kidney. 7/18/2017 44
  • 45.  Actions Of Somatostatin 1. Somatostatin acts within pancreas, inhibits β and α cells, 2. It decreases the motility of stomach, duodenum and gallbladder 3. It reduces the secretion of gastrin, CCK, GIP and VIP 4. Hypothalamic somatostatin inhibits the secretion of GH and TSH 7/18/2017 45
  • 46. Regulation Of Secretion Of Somatostatin  Pancreatic Somatostatin  Secretion of pancreatic somatostatin is stimulated by glucose, amino acids and CCK.  The tumor of D cells of islets of Langerhans causes hypersecretion of somatostatin.  It leads to hyperglycemia and other symptoms of diabetes mellitus. 7/18/2017 46
  • 47. Pancreatic Polypeptide  Source Of Secretion ◦ Pancreatic polypeptide is secreted by F cells or PP cells in the islets of Langerhans of pancreas.  Chemistry And Half-life ◦ Pancreatic polypeptide is a polypeptide with 36 amino acids. ◦ Its half-life is 5 minutes. 7/18/2017 47
  • 48. Synthesis and metabolism  Pancreatic polypeptide is synthesized from preprohormone precursor called prepropancreatic polypeptide in the PP cells of islets  Pancreatic polypeptide is degraded and removed from circulation mainly in kidney. 7/18/2017 48
  • 49. Actions Of Pancreatic Polypeptide ◦ Exact physiological action of pancreatic polypeptide is not known. ◦ It is believed to increase the secretion of glucagon from α-cells in islets of Langerhans.  Pancreatic polypeptide brings out its actions through cAMP. 7/18/2017 49
  • 50.  Regulation Of Secretion ◦ Secretion of pancreatic polypeptide is stimulated by the presence of chyme containing more proteins in the small intestine. 7/18/2017 50
  • 52. Hypoglycemia  Hypoglycemia is common in insulin-treated diabetic patients and also occurs occasionally in patients treated with the oral hypoglycemic sulfonylurea agents.  Hypoglycemia may range from very mild lowering of glycemia (60-70 mg/dl) with minimal or no symptoms, to severe hypoglycemia with very low levels of glucose (<40 mg/dl) and neurologic impairment. 7/18/2017 52
  • 55. References  Guyton & Hall:2011, Textbook of Medical Physiology, 12th ed. Insulin, glucagon and DM chapter XIV,  Williams textbook of endocrinology, 13th edition.  Berney, and Levy, physiology, 6th edition.  L. Sherwood, human physiology, 7th edition.  Vander's, human physiology,11th edition. 7/18/2017 55